Logo Logo
Eine Ebene nach oben
Exportieren als [RSS feed] RSS 1.0 [RSS2 feed] RSS 2.0
Gruppiert nach: Dokumententyp | Veröffentlichungsdatum
Anzahl der Publikationen: 5

Zeitschriftenartikel

Rothenburger, Tamara; Thomas, Dominique; Schreiber, Yannick; Wratil, Paul R.; Pflantz, Tamara; Knecht, Kirsten; Digianantonio, Katie; Temple, Joshua; Schneider, Constanze; Baldauf, Hanna-Mari; McLaughlin, Katie-May; Rothweiler, Florian; Bilen, Berna; Farmand, Samira; Bojkova, Denisa; Costa, Rui; Ferreiros, Nerea; Geisslinger, Gerd; Oellerich, Thomas; Xiong, Yong; Keppler, Oliver T.; Wass, Mark N.; Michaelis, Martin und Cinatl, Jindrich (2021): Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells. In: Journal of Experimental & Clinical Cancer Research, Bd. 40, Nr. 1, 317

Thomas, Dominique; Chung, Caroline; Zhang, Yiye; Te, Alexis; Gratzke, Christian; Woo, Henry und Chughtai, Bilal (2019): Clinical Trials in Benign Prostatic Hyperplasia: A Moving Target of Success. In: European Urology Focus, Bd. 5, Nr. 6: S. 1101-1104

Oellerich, Thomas; Schneider, Constanze; Thomas, Dominique; Knecht, Kirsten M.; Buzovetsky, Olga; Kaderali, Lars; Schliemann, Christoph; Bohnenberger, Hanibal; Angenendt, Linus; Hartmann, Wolfgang; Wardelmann, Eva; Rothenburger, Tamara; Mohr, Sebastian; Scheich, Sebastian; Comoglio, Federico; Wilke, Anne; Stroebel, Philipp; Serve, Hubert; Michaelis, Martin; Ferreiros, Nerea; Geisslinger, Gerd; Xiong, Yong; Keppler, Oliver T. und Cinatl, Jindrich (2019): Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML. In: Nature Communications, Bd. 10, 3475 [PDF, 2MB]

Knecht, Kirsten M.; Buzovetsky, Olga; Schneider, Constanze; Thomas, Dominique; Srikanth, Vishok; Kaderali, Lars; Tofoleanu, Florentina; Reiss, Krystle; Ferreiros, Nerea; Geisslinger, Gerd; Batista, Victor S.; Ji, Xiaoyun; Cinatl, Jindrich; Keppler, Oliver T. und Xiong, Yong (2018): The structural basis for cancer drug interactions with the catalytic and allosteric sites of SAMHD1. In: Proceedings of the National Academy of Sciences of the United States of America, Bd. 115, Nr. 43, E10022-E10031

Schneider, Constanze; Oellerich, Thomas; Baldauf, Hanna-Mari; Schwarz, Sarah-Marie; Thomas, Dominique; Flick, Robert; Bohnenberger, Hanibal; Kaderali, Lars; Stegmann, Lena; Cremer, Anjali; Martin, Margarethe; Lohmeyer, Julian; Michaelis, Martin; Hornung, Veit; Schliemann, Christoph; Berdel, Wolfgang E.; Hartmann, Wolfgang; Wardelmann, Eva; Comoglio, Federico; Hansmann, Martin-Leo; Yakunin, Alexander F.; Geisslinger, Gerd; Stroebel, Philipp; Ferreiros, Nerea; Serve, Hubert; Keppler, Oliver T. und Cinatl, Jindrich (2017): SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia. In: Nature Medicine, Bd. 23, Nr. 2: S. 250-255

Diese Liste wurde am Sat Mar 23 20:14:50 2024 CET erstellt.